A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: Low response in patients previously treated with medroxyprogesterone-Reference-Cited by-同舟云学术

A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: Low response in patients previously treated with medroxyprogesterone

Published:1985-04 Issue:4 Volume:21 Page:423-428
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Alberto Pierre,Mermillod Bernadette,Kaplan Eli,Goldhirsch Aron,Obrecht Jean-Pierre,Jungi Felix,Martz Georg,Barrelet Laurent,Cavalli Franco

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Aminoglutethimide;Santen,1981

2. Basic studies on aminoglutethimide;Salhanick;Cancer Res (Suppl),1982

3. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors;Abdul-Hajj;Cancer Res (Suppl),1982

4. Comparative studies of aromatase inhibitors in cultured human breast cancer cells;MacIndoe;Cancer Res (Suppl),1982

5. Aminoglutethimide as an inhibitor of adrenal steroidogenesis;Cash,1967

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal therapies of metastatic breast cancer: the past and the present;Metastasis of Breast Cancer;2007

2. Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?;Annals of Oncology;2001-11

3. Primary endocrine therapy for advanced breast cancer: To start with tamoxifen or with medroxyprogesterone acetate?;Annals of Oncology;1993-11

4. Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen;Breast Cancer Research and Treatment;1992-06

5. Aromatase Inhibitors in Malignant Diseases of Aging;Drugs & Aging;1992